Workflow
外汇衍生品交易
icon
Search documents
晶瑞电材: 国信证券股份有限公司关于公司开展外汇衍生品交易业务的核查意见
Zheng Quan Zhi Xing· 2025-08-22 16:48
Core Viewpoint - The company and its subsidiaries plan to engage in foreign exchange derivative trading to hedge against currency fluctuations, thereby enhancing financial stability and risk management capabilities [2][3][7] Group 1: Basic Information on Foreign Exchange Derivative Trading - The primary investment objective is to mitigate risks associated with currency fluctuations due to the company's import and export activities, predominantly involving USD, JPY, and HKD [2][3] - The maximum contract value held on any trading day is expected to not exceed 6.5 million USD (or equivalent foreign currency), with a maximum margin and premium limit of 650,000 USD (or equivalent) [2][3][6] - The trading will be conducted with reputable domestic and foreign banks that have the qualifications for foreign exchange derivative trading [3][4] Group 2: Risk Analysis and Control Measures - The company aims to avoid speculative trading and focuses on hedging, although risks such as market liquidity and operational errors still exist [4][5] - Risk control measures include strict adherence to internal procedures, approval authority, and regular reporting of risk exposure changes to management [5][6] - The company has established a management system for foreign exchange derivative trading and has taken necessary risk control measures [7] Group 3: Approval Procedures - The board of directors has approved the foreign exchange derivative trading proposal, allowing the use of self-owned funds for the transactions without requiring shareholder approval [6][7] - The supervisory board supports the initiative, recognizing its potential to enhance financial stability and risk management without harming shareholder interests [6][7]
晶瑞电材: 董事会决议公告
Zheng Quan Zhi Xing· 2025-08-22 16:36
Group 1 - The board of directors of Jingrui Electronic Materials Co., Ltd. held its eighth meeting of the fourth session, with all nine directors present, ensuring compliance with legal and regulatory requirements [1] - The board approved the 2025 semi-annual report and the special report on the use of raised funds, with unanimous support from all directors [2][3] - The company proposed a cash dividend of 0.10 yuan (including tax) per share based on the total share capital of 1,059,574,198 shares as of June 30, 2025, without capital reserve conversion or stock distribution [2][3] Group 2 - The board plans to hold a temporary shareholders' meeting on September 16, 2025, to review the proposals that require shareholder approval [4] - The company will adjust the total cash dividend amount if there are changes in total share capital before the implementation of the profit distribution plan, maintaining the distribution ratio [2][3]
广博股份: 外汇衍生品交易业务管理制度(2025年8月)
Zheng Quan Zhi Xing· 2025-08-22 16:16
Core Points - The document outlines the management system for foreign exchange derivative trading at Guangbo Group Co., Ltd, aiming to standardize operations and enhance risk management [1][2][3] Group 1: General Principles - The foreign exchange derivative trading is defined as transactions aimed at mitigating exchange rate or interest rate risks based on the company's foreign currency payment and receipt needs [1] - The trading activities must comply with national laws and regulations, adhering to principles of legality, prudence, safety, and effectiveness [2][3] - The company is prohibited from engaging in speculative or illegal arbitrage trading [2] Group 2: Trading Approval Authority - The management must provide a feasibility analysis report for derivative trading, which requires board approval before execution [3][4] - If the expected margin and premium exceed 50% of the latest audited net profit or 5 million RMB, shareholder approval is also required [4] - Any derivative trading that exceeds board authority must be approved by the shareholders' meeting [4][5] Group 3: Management and Implementation - The finance department is responsible for the implementation and management of foreign exchange derivative trading, ensuring compliance with internal control systems [6][7] - The finance department must establish appropriate stop-loss limits and procedures for different types of derivatives [6][7] - Regular audits and checks on the progress of derivative trading projects are mandated to ensure compliance and risk management [7][8] Group 4: Information Disclosure - The company is required to disclose relevant information regarding foreign exchange derivative activities in accordance with regulations from the China Securities Regulatory Commission and the Shenzhen Stock Exchange [7][8] - The board must continuously monitor the execution and safety of derivative trading, taking immediate action in case of significant losses [7]
深天马A: 外汇衍生品交易业务管理制度(2025年8月)
Zheng Quan Zhi Xing· 2025-08-22 12:12
天马微电子股份有限公司 外汇衍生品交易业务管理制度 第三条 公司开展外汇衍生品交易业务只允许与经国家外汇管理总局和中 国人民银行批准、具有外汇衍生品交易业务经营资格的金融机构进行交易,不得 与前述金融机构之外的其他组织或个人进行交易。 第四条 公司进行外汇衍生品交易必须基于公司的外币收(付)款的谨慎预 测,外汇衍生品交易合约的外币金额不得超过外币收(付)款的谨慎预测量。外 汇衍生品交易的交割期间需与公司预测的外币回款时间相匹配,持仓时间一般不 得超过 12 个月或实货合同规定时间。 (2025 年 8 月修订) 第一章 总 则 为规范天马微电子股份有限公司(以下简称"公司")外汇衍生品交易业务及 相关信息披露工作,加强对外汇衍生品交易业务的管理,防范投资风险,健全和 完善公司外汇衍生品交易业务管理机制,确保公司资产安全,根据《中华人民共 和国公司法》《中华人民共和国证券法》《深圳证券交易所股票上市规则》《上 市公司信息披露管理办法》及《公司章程》等有关规定,结合公司实际情况,特 制定本制度。 第一条 本制度所指外汇衍生品业务主要是以汇率为标的资产的远期合约、 掉期业务为套期工具,旨在为降低主业范围内风险敞口而 ...
中际联合:拟增外汇衍生品交易额度至1.25亿美元
Xin Lang Cai Jing· 2025-08-22 07:57
Core Points - The company, Zhongji United (Beijing) Technology Co., Ltd., has proposed to increase its foreign exchange derivatives trading limit from a maximum of 35 million USD (or equivalent foreign currency) to a maximum of 125 million USD (or equivalent foreign currency) [1] - The proposal is subject to approval by the shareholders' meeting [1] - The increased trading limit will allow the company and its subsidiaries to use the funds in a rolling manner, utilizing their own capital [1]
润丰股份: 外汇衍生品交易业务管理制度
Zheng Quan Zhi Xing· 2025-08-21 16:59
Core Points - The company has established a set of regulations to manage foreign exchange derivative trading, ensuring compliance with relevant laws and safeguarding asset security [1][8] - The foreign exchange derivative trading activities are aimed at hedging against currency and interest rate risks, and must not involve speculation or arbitrage [2][3] - All foreign exchange derivative transactions must be conducted with qualified financial institutions approved by the State Administration of Foreign Exchange and the People's Bank of China [2][3] Summary by Sections Chapter 1: General Provisions - The regulations are designed to standardize the company's foreign exchange derivative trading and related information disclosure [1] - The term "foreign exchange derivative trading" includes various financial instruments used to mitigate currency and interest rate risks [1] Chapter 2: Operating Principles and Procedures - The company must adhere to principles of legality, prudence, safety, and effectiveness in foreign exchange derivative trading [2] - Transactions must be based on forecasts of foreign currency receipts and payments, and the amounts involved should not exceed these forecasts [2][3] Chapter 3: Approval Procedures - All foreign exchange derivative transactions require board approval, especially those exceeding 20% of the latest audited net assets or 50 million yuan [3][4] - The management is responsible for executing transactions within the approved limits [4] Chapter 4: Information Disclosure - The company’s securities department is responsible for ensuring compliance with disclosure requirements related to foreign exchange derivative trading [5][6] - Any significant risks or losses must be disclosed promptly through temporary announcements [5] Chapter 5: Information Isolation Measures - All personnel involved in foreign exchange derivative trading must adhere to confidentiality protocols [6] Chapter 6: Internal Risk Reporting and Management Procedures - The company must implement measures to assess and mitigate risks associated with foreign exchange derivative trading [7] - The finance department is tasked with monitoring market prices and evaluating risks related to counterparties [7][8] Chapter 7: Supplementary Provisions - Any matters not covered by these regulations will be governed by relevant national laws and regulations [8]
广康生化: 华泰联合证券有限责任公司关于广东广康生化科技股份有限公司继续开展外汇衍生品交易业务的核查意见
Zheng Quan Zhi Xing· 2025-08-21 09:13
Core Viewpoint - The company, Guangdong Guokang Biochemical Technology Co., Ltd., aims to continue its foreign exchange derivatives trading to mitigate risks associated with currency fluctuations and enhance financial stability [1][10]. Group 1: Purpose of Foreign Exchange Derivatives Trading - The primary objective of engaging in foreign exchange derivatives trading is to effectively hedge against foreign exchange market risks and prevent adverse impacts from significant currency fluctuations [1]. - The company plans to engage with qualified banks and financial institutions to conduct these transactions [1]. Group 2: Basic Details of the Trading Business - The company intends to utilize its own funds for foreign exchange derivatives trading, with a total limit not exceeding $50 million [2]. - The expected maximum margin and premium for these transactions will not exceed $4 million [2]. - The trading will involve currencies used in the company's overseas operations, primarily the US dollar, and will include various products such as forward foreign exchange settlements, foreign exchange swaps, and options [1][2]. Group 3: Risk Management Measures - The company will adhere to principles of legality, prudence, safety, and effectiveness in its trading activities, avoiding speculative transactions [4][8]. - A clear set of operational norms, approval authorities, and risk management procedures will be established to control trading risks [8]. Group 4: Impact on the Company - The foreign exchange derivatives trading is closely related to the company's operational activities, enhancing its ability to manage foreign exchange risks and reducing financial costs [5][10]. - The trading activities are expected to strengthen the company's financial stability without harming the interests of the company or its shareholders [5][10]. Group 5: Accounting Policies and Procedures - The company will follow relevant accounting standards for financial instruments and hedge accounting to reflect the transactions in its financial statements [9]. Group 6: Approval Process - The board of directors approved the continuation of foreign exchange derivatives trading on August 20, 2025, with the authorization effective from September 23, 2025, for a period of 12 months [9][10]. - The audit committee has confirmed the necessity and compliance of the decision-making process regarding the trading activities [10].
广康生化拟开展不超5000万美元外汇衍生品交易业务
Xin Lang Cai Jing· 2025-08-21 08:36
Core Viewpoint - Guangkang Biochemical (300804) has approved the continuation of foreign exchange derivative trading, with a total limit of up to 50 million USD for the next 12 months, starting from September 23 [1] Group 1: Business Operations - The company plans to use its own funds for foreign exchange derivative trading, primarily involving USD, through methods such as forward foreign exchange contracts [1] - The previous authorization for this trading activity is set to expire on September 23, and the new authorization will be effective for 12 months with funds being reusable [1] Group 2: Risk Management - The company acknowledges potential risks associated with market fluctuations and exchange rate volatility, and has established corresponding management measures to mitigate these risks [1] - The trading business is closely related to the company's operations and is expected to enhance financial stability [1] Group 3: Governance and Approval - The proposal has been approved by the board of directors and the audit committee, with no objections from the sponsor [1]
浙江东南网架股份有限公司 第八届董事会第二十五次会议决议公告
Zheng Quan Shi Bao· 2025-08-19 19:54
Core Viewpoint - The company has approved a plan to engage in foreign exchange derivative hedging to mitigate risks associated with currency fluctuations, enhancing financial stability while ensuring that core business operations remain unaffected [3][12][25]. Group 1: Board Meeting Details - The company's 25th meeting of the 8th Board of Directors was held on August 19, 2025, with all 9 directors present, confirming the legality and validity of the meeting [2][3]. - The board unanimously approved the proposal for foreign exchange derivative hedging with a vote of 9 in favor, 0 against, and 0 abstentions [3][4]. Group 2: Foreign Exchange Derivative Hedging Proposal - The company plans to conduct foreign exchange derivative hedging with a maximum transaction amount of up to $80 million or equivalent foreign currency, which can be rolled over within a 12-month period [3][12][15]. - The hedging activities are aimed at preventing adverse impacts from foreign currency exchange rate fluctuations and enhancing the company's financial resilience [12][14]. Group 3: Monitoring and Risk Management - The company has established a comprehensive risk management framework to monitor foreign exchange market conditions and adjust strategies accordingly to minimize potential losses [22]. - The financial department will oversee all foreign exchange derivative transactions, ensuring they are based on actual business needs and not speculative in nature [22][23]. Group 4: Compliance and Approval Process - The proposal for foreign exchange derivative hedging was reviewed and approved by both the Board of Directors and the Supervisory Board, confirming compliance with relevant laws and regulations [19][20][25]. - The company has developed a specific management system for foreign exchange derivative transactions to ensure adherence to regulatory requirements and internal controls [4][25].
安凯微: 广州安凯微电子股份有限公司第二届董事会第十四次会议决议公告
Zheng Quan Zhi Xing· 2025-08-13 16:23
证券代码:688620 证券简称:安凯微 公告编号:2025-044 广州安凯微电子股份有限公司 第二届董事会第十四次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 一、董事会会议召开情况 广州安凯微电子股份有限公司(以下简称"公司")第二届董事会第十四次会 议于 2025 年 8 月 12 日 10:30-11:00 在公司会议室以现场与通讯相结合的方式召开。 本次会议的通知已于 2025 年 8 月 1 日以通讯方式送达公司全体董事。本次会议由公 司董事长 NORMAN SHENGFA HU(胡胜发)[以下简称"胡胜发"]先生主持,会 议应出席董事 7 名,实际出席董事 7 名。本次会议的召集、召开和表决程序符合 《中华人民共和国公司法》(以下简称"《公司法》")等法律、法规、规范性文件 和《广州安凯微电子股份有限公司章程》(以下简称"《公司章程》")、《广州安凯 微电子股份有限公司董事会议事规则》的规定,会议决议合法、有效。 二、董事会会议审议情况 (一)审议通过《关于2025年半年度报告及其摘要的议案 ...